| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |